Formosa Laboratories Stock

Formosa Laboratories EBIT Margin

The EBIT Margin (Operating Margin) of Formosa Laboratories (4746.TW) as of Aug 4, 2026 is 16.56 %. In the previous year, EBIT Margin (Operating Margin) was 15.85 % — a change of 4.43% (higher).

EBIT Margin

16.56 %

YoY

4.43%

Last updated:

EBIT Margin (Operating Margin) of Formosa Laboratories is 2026 16.56 % . EBIT Margin (Operating Margin) of Formosa Laboratories was 2025 15.85 % . It decreases by 4.43% higher compared to the previous year.

For Formosa Laboratories, the operating (EBIT) margin of 16.6% is down versus 35.1% a few years ago.

Access this data via the Eulerpool API

Formosa Laboratories Stock analysis

What does Formosa Laboratories do? Formosa Laboratories, Inc. is a renowned company in the field of research and development, pharmaceuticals, and diagnostics, operating in the industry for over 30 years. Founded in 1989, the company has become one of the leading providers of innovative solutions and products that allow its customers to improve their healthcare and enhance their quality of life. The business model of Formosa Laboratories is focused on meeting the high demands of its customers. The company works closely with medical professionals, scientists, and researchers to develop products that meet the needs of patients. With an experienced and diverse team of experts in areas such as research and development, quality control, production, marketing, and sales, Formosa Laboratories is able to offer fast and effective solutions for all customer requirements. The company has divided its various business areas into different divisions, each specialized in different areas of medicine and diagnostics. The three main business divisions are research and development, pharmaceuticals, and diagnostics. In the field of research and development, the company offers services such as preclinical research, biologics research, and development strategies. The company is dedicated to researching new control procedures and technologies to ensure the effectiveness of its solutions. Formosa Laboratories takes pride in its innovative research and development team, which stays up to date with the latest technology and continuously develops new products to meet the needs of its customers. In the pharmaceutical field, the company offers a wide range of prescription and non-prescription medications prescribed by doctors around the world. Formosa Laboratories relies on close collaboration with its customers to ensure that each patient receives the best possible medical care. The company is committed to manufacturing high-quality and safe medications. In the field of diagnostics, the company offers a variety of diagnostic tests and kits that allow for accurate and fast diagnosis of various diseases and conditions. With advanced technology and precise test results, Formosa Laboratories helps doctors and medical professionals make quick and accurate diagnoses to start treatment as soon as possible. Over the years, Formosa Laboratories has developed numerous products that have improved people's lives and fought against diseases. Some of the company's well-known products include: - Influenza Rapid Tests: A fast and accurate test for diagnosing the flu. - Pregnancy Test Kits: A traditional pregnancy test that is able to confirm or exclude pregnancy in a woman. - Needle-free Syringes: An innovation that allows for medication injection without a needle. In conclusion, Formosa Laboratories Inc is a significant company in the medical and diagnostics industry, dedicated to manufacturing high-quality and safe products. With its experienced and qualified team, the company is able to offer fast and effective solutions tailored to the individual needs of its customers. Formosa Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Formosa Laboratories stock

EBIT Margin (Operating Margin) of Formosa Laboratories is 16.56 % in 2026.

EBIT Margin (Operating Margin) of Formosa Laboratories changed from 15.85 % to 16.56 %, representing a 4.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Formosa Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Formosa Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

Margins — Formosa Laboratories

All Key Metrics — Formosa Laboratories